Hesham Abboud

2.1k total citations
58 papers, 887 citations indexed

About

Hesham Abboud is a scholar working on Neurology, Pathology and Forensic Medicine and Rheumatology. According to data from OpenAlex, Hesham Abboud has authored 58 papers receiving a total of 887 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Neurology, 22 papers in Pathology and Forensic Medicine and 9 papers in Rheumatology. Recurrent topics in Hesham Abboud's work include Peripheral Neuropathies and Disorders (23 papers), Multiple Sclerosis Research Studies (20 papers) and Neurological disorders and treatments (15 papers). Hesham Abboud is often cited by papers focused on Peripheral Neuropathies and Disorders (23 papers), Multiple Sclerosis Research Studies (20 papers) and Neurological disorders and treatments (15 papers). Hesham Abboud collaborates with scholars based in United States, Egypt and South Korea. Hesham Abboud's co-authors include Alessandro Serra, Michael Levy, Maureen A. Mealy, Hubert H. Fernandez, Hannah Kelly, Brent S. Sokola, Eddie Hill, Farren Briggs, Scott E. Cooper and Anwar Ahmed and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Frontiers in Immunology.

In The Last Decade

Hesham Abboud

50 papers receiving 874 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hesham Abboud United States 19 589 456 157 106 87 58 887
Naraporn Prayoonwiwat Thailand 18 490 0.8× 609 1.3× 106 0.7× 200 1.9× 42 0.5× 66 927
Amir‐Hadi Maghzi United States 19 291 0.5× 569 1.2× 115 0.7× 144 1.4× 53 0.6× 44 960
Sara Salama Egypt 10 473 0.8× 446 1.0× 102 0.6× 166 1.6× 25 0.3× 22 637
Michael Karenfort Germany 13 430 0.7× 493 1.1× 37 0.2× 162 1.5× 82 0.9× 32 828
Yael Stern Israel 11 258 0.4× 526 1.2× 170 1.1× 67 0.6× 25 0.3× 15 679
O. Heinzlef France 10 235 0.4× 311 0.7× 64 0.4× 139 1.3× 56 0.6× 18 531
Julia O’Mahony Canada 16 325 0.6× 589 1.3× 37 0.2× 146 1.4× 47 0.5× 43 840
Damien Biotti France 15 293 0.5× 287 0.6× 36 0.2× 95 0.9× 29 0.3× 61 606
David Magalashvili Israel 16 385 0.7× 810 1.8× 441 2.8× 84 0.8× 32 0.4× 48 1.1k
Mahdi Barzegar Iran 14 297 0.5× 452 1.0× 161 1.0× 73 0.7× 10 0.1× 58 664

Countries citing papers authored by Hesham Abboud

Since Specialization
Citations

This map shows the geographic impact of Hesham Abboud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hesham Abboud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hesham Abboud more than expected).

Fields of papers citing papers by Hesham Abboud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hesham Abboud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hesham Abboud. The network helps show where Hesham Abboud may publish in the future.

Co-authorship network of co-authors of Hesham Abboud

This figure shows the co-authorship network connecting the top 25 collaborators of Hesham Abboud. A scholar is included among the top collaborators of Hesham Abboud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hesham Abboud. Hesham Abboud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abboud, Hesham, Stacey Clardy, Divyanshu Dubey, et al.. (2025). The Clinical Trial Landscape in Autoimmune Encephalitis. Neurology. 104(8). e213487–e213487. 4 indexed citations
2.
Abboud, Hesham, Brian Steingo, Diana Vargas, et al.. (2025). Satralizumab treatment in patients with AQP4-IgG–seropositive neuromyelitis optica spectrum disorder after rituximab treatment: A case series. Journal of Neuroimmunology. 403. 578585–578585.
3.
Abboud, Hesham, et al.. (2025). Switch from eculizumab to satralizumab in aquaporin 4 immunoglobulin G–seropositive neuromyelitis optica spectrum disorder: a case series report. Frontiers in Immunology. 15. 1526563–1526563. 1 indexed citations
4.
Abboud, Hesham, et al.. (2024). Spinal movement disorders in NMOSD, MOGAD, and idiopathic transverse myelitis: a prospective observational study. Journal of Neurology. 271(9). 5875–5885. 2 indexed citations
5.
Morgan, Michael M., et al.. (2023). Utility of the 2023 international MOGAD panel proposed criteria in clinical practice: An institutional cohort. Multiple Sclerosis and Related Disorders. 81. 105150–105150. 14 indexed citations
6.
Abboud, Hesham, et al.. (2023). Spinal dystonia and other spinal movement disorders. SHILAP Revista de lepidopterología. 2. 5 indexed citations
7.
Serra, Alessandro, et al.. (2023). Predicting the final clinical phenotype after the first attack of optic neuritis. Journal of Neuroimmunology. 381. 578130–578130. 3 indexed citations
8.
Serra, Alessandro, et al.. (2022). The humoral response to SARS-COV-2 vaccines in MS patients: A case series exploring the impact of DMT, lymphocyte count, immunoglobulins, and vaccine type. Multiple Sclerosis and Related Disorders. 61. 103785–103785. 6 indexed citations
9.
Kelly, Hannah, Brent S. Sokola, & Hesham Abboud. (2021). Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients. Journal of Neuroimmunology. 356. 577599–577599. 62 indexed citations
10.
Zare-Shahabadi, Ameneh, et al.. (2021). Progressive myelopathy in myelin oligodendrocyte glycoprotein antibody-associated disease: A new mimicker of progressive multiple sclerosis?. Multiple Sclerosis and Related Disorders. 52. 102964–102964. 9 indexed citations
11.
12.
Patel, Mohit, et al.. (2020). Nonscalpel myelopathy: Cervical myelopathy secondary to neuromyelitis optica. Journal of Craniovertebral Junction and Spine. 11(1). 55–55.
13.
Ismail, Ismail Ibrahim, et al.. (2020). CNS demyelination during tofacitinib therapy: First report. Multiple Sclerosis and Related Disorders. 46. 102568–102568. 23 indexed citations
14.
Abboud, Hesham, et al.. (2019). Defining the spectrum of spasticity-associated involuntary movements. Parkinsonism & Related Disorders. 65. 79–85. 5 indexed citations
15.
Abboud, Hesham, et al.. (2019). Height and weight changes after deep brain stimulation in patients with Parkinson disease: role of clinical subtypes. Heliyon. 5(6). e01862–e01862. 4 indexed citations
16.
Hill, Eddie, Hesham Abboud, & Farren Briggs. (2018). Prevalence of asthma in multiple sclerosis: A United States population-based study. Multiple Sclerosis and Related Disorders. 28. 69–74. 24 indexed citations
17.
Abboud, Hesham, Ian Rossman, Maureen A. Mealy, et al.. (2017). Neuronal autoantibodies: differentiating clinically relevant and clinically irrelevant results. Journal of Neurology. 264(11). 2284–2292. 20 indexed citations
18.
Abboud, Hesham, Eddie Hill, Junaid Siddiqui, Alessandro Serra, & Benjamin L. Walter. (2017). Neuromodulation in multiple sclerosis. Multiple Sclerosis Journal. 23(13). 1663–1676. 43 indexed citations
19.
Abboud, Hesham, et al.. (2015). Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange. Multiple Sclerosis Journal. 22(2). 185–192. 164 indexed citations
20.
Abboud, Hesham, Anwar Ahmed, & Hubert H. Fernandez. (2011). Essential tremor: Choosing the right management plan for your patient. Cleveland Clinic Journal of Medicine. 78(12). 821–828. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naraporn Prayoonwiwat Breakdown of academic impact, for papers by Amir‐Hadi Maghzi Breakdown of academic impact, for papers by Sara Salama Breakdown of academic impact, for papers by Michael Karenfort Breakdown of academic impact, for papers by Yael Stern Breakdown of academic impact, for papers by O. Heinzlef Breakdown of academic impact, for papers by Julia O’Mahony Breakdown of academic impact, for papers by Damien Biotti Breakdown of academic impact, for papers by David Magalashvili Breakdown of academic impact, for papers by Mahdi Barzegar
Rankless by CCL
2026